Creating a platform to explore and manipulate the human microbiome.
Designing a High-Throughput Platform to Bioprospect the Human Microbiome and ManipulateIts Iinterplay with Host Environments
This study is working on new ways to grow and understand the tiny microbes in our gut that affect our health, with the goal of helping people feel better by creating personalized treatments based on their unique microbiome.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Carnegie-Mellon University NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11046196 on NIH RePORTER |
What this research studies
This research focuses on developing a high-throughput platform to study the human microbiome, which consists of various microbial species that play essential roles in health and disease. The project aims to create innovative technologies that can isolate and culture previously unculturable microbes from the gut, allowing for a better understanding of their interactions with the host environment. By manipulating these microbial communities, the research seeks to restore balance in the gut microbiome, potentially improving health outcomes for patients with various conditions. The approach involves advanced microfluidic technology to enable personalized treatments based on individual microbiome profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals experiencing gut-related health issues or those with conditions linked to microbiome imbalances.
Not a fit: Patients with stable gut health or those not experiencing any microbiome-related conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to personalized microbiome therapies that restore gut health and improve overall patient well-being.
How similar studies have performed: Other research has shown promise in manipulating the microbiome for health benefits, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Pittsburgh, United States
- Carnegie-Mellon University — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Niepa, Tagbo Herman Roland — Carnegie-Mellon University
- Study coordinator: Niepa, Tagbo Herman Roland
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.